Insider Transactions in Q4 2020 at Foghorn Therapeutics Inc. (FHTX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 27
2020
|
Adrian Gottschalk Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
25,225
+50.0%
|
-
|
|
Oct 27
2020
|
Carl Decicco Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
5,500
+2.08%
|
$88,000
$16.0 P/Share
|
|
Oct 27
2020
|
Flagship Ventures Fund V General Partner LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
150,000
+2.14%
|
$2,400,000
$16.0 P/Share
|
|
Oct 27
2020
|
Flagship Ventures Fund V General Partner LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
12,524,120
+38.34%
|
-
|
|
Oct 27
2020
|
Investment Authority Abu Dhabi |
BUY
Open market or private purchase
|
Direct |
150,000
+10.86%
|
$2,400,000
$16.0 P/Share
|
|
Oct 27
2020
|
Investment Authority Abu Dhabi |
BUY
Conversion of derivative security
|
Direct |
1,081,081
+50.0%
|
-
|